Success Metrics

Clinical Success Rate
95.5%

Based on 21 completed trials

Completion Rate
95%(21/22)
Active Trials
0(0%)
Results Posted
29%(6 trials)
Terminated
1(4%)

Phase Distribution

Ph early_phase_1
2
8%
Ph phase_1
1
4%
Ph phase_2
4
17%
Ph phase_3
3
13%
Ph not_applicable
14
58%

Phase Distribution

3

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution24 total trials
Early Phase 1First-in-human
2(8.3%)
Phase 1Safety & dosage
1(4.2%)
Phase 2Efficacy & side effects
4(16.7%)
Phase 3Large-scale testing
3(12.5%)
N/ANon-phased studies
14(58.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

95.5%

21 of 22 finished

Non-Completion Rate

4.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

24

all time

Status Distribution
Active(1)
Completed(21)
Terminated(1)
Other(1)

Detailed Status

Completed21
unknown1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
0
Success Rate
95.5%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (8.3%)
Phase 11 (4.2%)
Phase 24 (16.7%)
Phase 33 (12.5%)
N/A14 (58.3%)

Trials by Status

unknown14%
completed2188%
terminated14%
not_yet_recruiting14%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT07286318Early Phase 1

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Not Yet Recruiting
NCT06640244Not Applicable

The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening

Completed
NCT06366503Not Applicable

Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation

Completed
NCT05736224Phase 1

Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen

Completed
NCT06633731Not Applicable

Clinical Case Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment on Healthy Females with Fitzpatrick Skin Types V and VI

Completed
NCT06436261Not Applicable

Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial Rejuvenation

Completed
NCT06157853Not Applicable

Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation

Completed
NCT05327361Phase 2

LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)

Terminated
NCT05272787Not Applicable

Clinical Trial to Evaluate Safety and Efficacy of a Facial and Lip Moisturizer in Adult Subjects Undergoing a Facial Dermatologic Procedure With Fractional CO2 Laser

Completed
NCT01874860Phase 2

Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients

Completed
NCT05271136Not Applicable

A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum

Completed
NCT05089851Not Applicable

Investigation of the Efficacy and Tolerability of a Cosmetic Product With Onabotulinumtoxin A in the Treatment of Facial Lines

Completed
NCT04545970Not Applicable

A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines

Completed
NCT01867294Phase 2

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Completed
NCT04065035Not Applicable

A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming

Completed
NCT03197883Not Applicable

Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure

Completed
NCT03287791Phase 3

A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea

Completed
NCT03302559Not Applicable

Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage

Completed
NCT03751163Phase 3

Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma

Completed
NCT03392623Early Phase 1

DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.

Completed

Drug Details

Intervention Type
DRUG
Total Trials
24